<VariationArchive VariationID="225048" VariationName="NM_018368.4(LMBRD1):c.1056del (p.Asn353fs)" VariationType="Deletion" Accession="VCV000225048" Version="40" RecordType="classified" NumberOfSubmissions="12" NumberOfSubmitters="12" DateLastUpdated="2024-07-15" DateCreated="2016-10-09" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="226902" VariationID="225048">
      <GeneList>
        <Gene Symbol="LMBRD1" FullName="LMBR1 domain containing 1" GeneID="55788" HGNC_ID="HGNC:23038" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="69674010" stop="69797010" display_start="69674010" display_stop="69797010" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="70385640" stop="70507048" display_start="70385640" display_stop="70507048" Strand="-" />
          </Location>
          <OMIM>612625</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018368.4(LMBRD1):c.1056del (p.Asn353fs)</Name>
      <CanonicalSPDI>NC_000006.12:69701469:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="69701470" stop="69701470" display_start="69701470" display_stop="69701470" variantLength="1" positionVCF="69701469" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="70411362" stop="70411362" display_start="70411362" display_stop="70411362" variantLength="1" positionVCF="70411361" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>N280fs</ProteinChange>
      <ProteinChange>N353fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.70411362del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.70411362del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.69701470del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.69701470del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016012.2" sequenceAccession="NG_016012" sequenceVersion="2" change="g.170147del">
            <Expression>NG_016012.2:g.170147del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363722.2" sequenceAccession="NM_001363722" sequenceVersion="2" change="c.837del">
            <Expression>NM_001363722.2:c.837del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350651.1" sequenceAccession="NP_001350651" sequenceVersion="1" change="p.Asn280fs">
            <Expression>NP_001350651.1:p.Asn280fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001367271.1" sequenceAccession="NM_001367271" sequenceVersion="1" change="c.837del">
            <Expression>NM_001367271.1:c.837del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354200.1" sequenceAccession="NP_001354200" sequenceVersion="1" change="p.Asn280fs">
            <Expression>NP_001354200.1:p.Asn280fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001367272.1" sequenceAccession="NM_001367272" sequenceVersion="1" change="c.837del">
            <Expression>NM_001367272.1:c.837del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354201.1" sequenceAccession="NP_001354201" sequenceVersion="1" change="p.Asn280fs">
            <Expression>NP_001354201.1:p.Asn280fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018368.4" sequenceAccession="NM_018368" sequenceVersion="4" change="c.1056del" MANESelect="true">
            <Expression>NM_018368.4:c.1056del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060838.3" sequenceAccession="NP_060838" sequenceVersion="3" change="p.Asn353fs">
            <Expression>NP_060838.3:p.Asn353fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1310" sequenceAccession="LRG_1310">
            <Expression>LRG_1310:g.170147del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1310t1" sequenceAccession="LRG_1310t1">
            <Expression>LRG_1310t1:c.1056del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1310p1" sequenceAccession="LRG_1310p1" change="p.Asn353fs">
            <Expression>LRG_1310p1:p.Asn353fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA358088" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="612625.0001" DB="OMIM" />
        <XRef Type="rs" ID="749272546" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00040" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00046" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00053" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00062" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00072" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018368.4(LMBRD1):c.1056del (p.Asn353fs) AND Inborn genetic diseases" Accession="RCV000210618" Version="3">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-11-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018368.4(LMBRD1):c.1056del (p.Asn353fs) AND not provided" Accession="RCV000255705" Version="22">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-12-21" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018368.4(LMBRD1):c.1056del (p.Asn353fs) AND Methylmalonic aciduria and homocystinuria type cblF" Accession="RCV000778799" Version="17">
        <ClassifiedConditionList TraitSetID="144">
          <ClassifiedCondition DB="MedGen" ID="C1848578">Methylmalonic aciduria and homocystinuria type cblF</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-29" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018368.4(LMBRD1):c.1056del (p.Asn353fs) AND Cobalamin C disease" Accession="RCV002509305" Version="2">
        <ClassifiedConditionList TraitSetID="384">
          <ClassifiedCondition DB="MedGen" ID="C1848561">Cobalamin C disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018368.4(LMBRD1):c.1056del (p.Asn353fs) AND Disorders of Intracellular Cobalamin Metabolism" Accession="RCV002517437" Version="2">
        <ClassifiedConditionList TraitSetID="13518">
          <ClassifiedCondition DB="MedGen" ID="CN043592">Disorders of Intracellular Cobalamin Metabolism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-29" NumberOfSubmissions="12" NumberOfSubmitters="12" DateCreated="2016-10-09" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19136951</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21303734</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23776111</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24664876</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26997947</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301503</ID>
          <ID Source="BookShelf">NBK1328</ID>
        </Citation>
        <DescriptionHistory Dated="2017-12-19">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2016-10-09">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13518" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9483" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Disorders of Intracellular Cobalamin Metabolism</ElementValue>
                <XRef ID="296703" DB="GeneTests" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                <XRef ID="NBK1328" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301503</ID>
                <ID Source="BookShelf">NBK1328</ID>
              </Citation>
              <XRef ID="CN043592" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="144" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2776" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COBALAMIN F DISEASE</ElementValue>
                <XRef Type="MIM" ID="277380" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">COBALAMIN, DEFECT IN LYSOSOMAL RELEASE OF</ElementValue>
                <XRef Type="MIM" ID="277380" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Methylmalonic aciduria and homocystinuria type cblF</ElementValue>
                <XRef ID="MONDO:0010183" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblF TYPE</ElementValue>
                <XRef Type="MIM" ID="277380" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">METHYLMALONIC ACIDURIA DUE TO VITAMIN B12-RELEASE DEFECT</ElementValue>
                <XRef Type="MIM" ID="277380" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VITAMIN B12 LYSOSOMAL RELEASE DEFECT</ElementValue>
                <XRef Type="MIM" ID="277380" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VITAMIN B12 STORAGE DISEASE</ElementValue>
                <XRef Type="MIM" ID="277380" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">cblF</ElementValue>
                <XRef Type="MIM" ID="277380" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3584" />
                <XRef ID="3584" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                <XRef ID="NBK1328" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301503</ID>
                <ID Source="BookShelf">NBK1328</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="79284" DB="Orphanet" />
              <XRef ID="C1848578" DB="MedGen" />
              <XRef ID="MONDO:0010183" DB="MONDO" />
              <XRef Type="MIM" ID="277380" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="384" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5516" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cobalamin-C methylmalonic acidemia and homocystinuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic acidemia and homocystinuria cblC type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic aciduria and homocystinuria, Vitamin B12-responsive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vitamin B12 metabolic defect with combined deficiency of methylmalonyl-CoA mutase and homocysteine:methyltetrahydrofolate methyltransferase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cobalamin C disease</ElementValue>
                <XRef ID="74653006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">methylmalonic aciduria and homocystinuria type cblC</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                <XRef ID="NBK1328" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12128" />
                <XRef ID="12128" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301503</ID>
                <ID Source="BookShelf">NBK1328</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="26" DB="Orphanet" />
              <XRef ID="79282" DB="Orphanet" />
              <XRef ID="C1848561" DB="MedGen" />
              <XRef ID="MONDO:0010184" DB="MONDO" />
              <XRef Type="MIM" ID="277400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1190690" SubmissionDate="2017-10-05" DateLastUpdated="2016-10-09" DateCreated="2016-10-09">
        <ClinVarSubmissionID localKey="43504393" />
        <ClinVarAccession Accession="SCV000610635" DateUpdated="2016-10-09" DateCreated="2016-10-09" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.000647</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" Strand="+" alternateAllele="-" referenceAllele="C" start="70411362" stop="70411362" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="499714" SubmissionDate="2020-11-30" DateLastUpdated="2017-12-19" DateCreated="2016-04-09">
        <ClinVarSubmissionID localKey="a67838" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000262941" DateUpdated="2017-12-19" DateCreated="2016-04-09" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-11-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Autosomal Dominant and X-Linked criteria (10/2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/zfkfvckw/mid-7377_ambry_classification_scheme_oct_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMBRD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018368.3:c.1056del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="616952" SubmissionDate="2021-12-29" DateLastUpdated="2023-03-04" DateCreated="2016-10-09">
        <ClinVarSubmissionID localKey="GDXSV:218596" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000322299" DateUpdated="2023-03-04" DateCreated="2016-10-09" Type="SCV" Version="9" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24664876, 22065268, 19136951, 26997947, 23776111, 20127417, 21303734, 25533962, 31589614)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMBRD1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:691460</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018368.3:c.1056del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_54_20210928044205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_78_20211229054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="20694" SubmissionDate="2018-02-08" DateLastUpdated="2024-05-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612625.0001_METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE" title="LMBRD1, 1-BP DEL, 1056G_METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE" />
        <ClinVarAccession Accession="SCV000020694" DateUpdated="2024-05-12" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 7 patients with methylmalonic aciduria and homocystinuria type cblF (MAHCF; 277380), Rutsch et al. (2009) identified a homozygous 1-bp deletion (1056delG) in the LMBRD1 gene, resulting in a frameshift and premature termination. Four additional patients were compound heterozygous for the 1056delG mutation and another pathogenic mutation in the LMBRD1 gene (e.g., 612625.0003). The mutation was present in 18 of the 24 disease chromosomes, consistent with a common founder of European ancestry. The phenotype was variable, ranging from developmental delay to asymptomatic long-term survival. In vitro functional expression studies in patient cells showed that the biochemical defect could be rescued by transfection of the wildtype protein.</Attribute>
              <Citation>
                <ID Source="PubMed">19136951</ID>
              </Citation>
              <XRef DB="OMIM" ID="277380" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMBRD1" />
          </GeneList>
          <Name>LMBRD1, 1-BP DEL, 1056G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1056G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612625.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790250" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1399111" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915179" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24664876</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26997947</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21303734</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19136951</ID>
          </Citation>
          <Comment>The LMBRD1 c.1056delG (p.Asn353IlefsTer18) variant results in a frameshift and is predicted to result in premature termination of the protein. Across a selection of the available literature, the p.Asn353IlefsTer18 variant has been identified in 11 individuals with disorders of intracellular cobalamin metabolism, including in a homozygous state in eight and in a compound heterozygous state in three (Rutsch et al. 2009; Miousse et al. 2011; Constantinou et al. 2016). An additional deceased proband with cobalamin deficiency was found to carry the p.Asn353IlefsTer18 variant and a second variant in the MTR gene, suggesting the possibility of digenic inheritance (Farwell Gonzalez et al. 2015). Phenotypic symptoms cover a wide range of symptoms including failure to thrive, neutropenia, developmental delay, stomatitis, megaloblastic anemia, and feeding difficulties; however, some patients may show asymptomatic long-term survival (Rutsch et al. 2009). Control data are unavailable for this variant, which is reported at a frequency of 0.00109 in the European American population of the Exome Sequencing Project. Transfection of immortalized fibroblasts from a compound heterozygous proband and a homozygous proband with wildtype LMBD1 was able to rescue the biochemical intracellular cobalamin pathway F (cblF) phenotype (Rutsch et al. 2009). Based on the collective evidence and the potential impact of frameshift variants, the p.Asn353IlefsTer18 variant is classified as pathogenic for disorders of intracellular cobalamin metabolism. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMBRD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="T" referenceAllele="TC" start="70411361" stop="70411362" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018368.3:c.1056delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277380" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3001966" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_018368.3:c.1056delG|OMIM:277380" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001526751" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19136951</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24664876</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23776111</ID>
          </Citation>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This pathogenic variant has been previously reported in patients with methylmalonic aciduria and homocystinuria type cblF (MMAHCF) [PMID 19136951, 24664876, 23776111]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMBRD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018368.3:c.1056delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277380" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5464018" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_018368.4:c.1056del|OMIM:277380" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002811500" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018368.4:c.1056del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277380" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5504487" SubmissionDate="2023-01-11" DateLastUpdated="2023-01-15" DateCreated="2023-01-15">
        <ClinVarSubmissionID localKey="NM_018368.3:c.1056delG|MedGen:C1848561" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002819365" DateUpdated="2023-01-15" DateCreated="2023-01-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21303734</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19136951</ID>
          </Citation>
          <Comment>Variant summary: LMBRD1 c.1056delG (p.Asn353IlefsX18) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic in ClinVar and is associated with Methylmalonic aciduria &amp; homocystinuria in HGMD. The variant allele was found at a frequency of 0.00046 in 248514 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in LMBRD1 causing Methylmalonic Acidemia With Homocystinuria (0.00046 vs 0.00079), allowing no conclusion about variant significance. c.1056delG has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Methylmalonic Acidemia With Homocystinuria and the variant segregated with disease (examples: Rutsch_2009 and Miousse_2011). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in &lt;10% of normal activity (Rutsch_2009). Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMBRD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018368.3:c.1056delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848561" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12529442</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6043649" SubmissionDate="2023-01-25" DateLastUpdated="2023-02-07" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="NM_018368.3:c.1056delG|MedGen:CN043592" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV003354492" DateUpdated="2023-02-07" DateCreated="2023-02-07" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="Bookshelf">NBK1328</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19136951</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018368.3:c.1056delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043592" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12628976</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3967178" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="d892bd6e08162313246ff85cb7234d65e575af84afa4cc66faf687fc1d9628be|OMIM:277380" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002017151" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018368.4:c.1056del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277380" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1852605" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="3050901|MedGen:C1848578" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000958342" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19136951</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21303734</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19136951</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21303734</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23776111</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26997947</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19136951</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn353Ilefs*18) in the LMBRD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LMBRD1 are known to be pathogenic (PMID: 19136951, 21303734). This variant is present in population databases (rs749272546, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individuals with Cobalamin F (cblF) deficiency (PMID: 19136951, 21303734, 23776111, 26997947). It is commonly reported in individuals of European ancestry (PMID: 19136951). ClinVar contains an entry for this variant (Variation ID: 225048). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMBRD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.70411362del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848578" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4044903" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-01-26">
        <ClinVarSubmissionID localKey="111293|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002062682" DateUpdated="2024-07-15" DateCreated="2022-01-26" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMBRD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="T" referenceAllele="TC" start="70411361" stop="70411362" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5504487" TraitType="Disease" MappingType="XRef" MappingValue="C1848561" MappingRef="MedGen">
        <MedGen CUI="C1848561" Name="Cobalamin C disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4044903" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1190690" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20694" TraitType="Disease" MappingType="Name" MappingValue="METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE" MappingRef="Preferred">
        <MedGen CUI="C1848578" Name="Methylmalonic aciduria and homocystinuria type cblF" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="616952" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1852605" TraitType="Disease" MappingType="XRef" MappingValue="C1848578" MappingRef="MedGen">
        <MedGen CUI="C1848578" Name="Methylmalonic aciduria and homocystinuria type cblF" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3967178" TraitType="Disease" MappingType="XRef" MappingValue="277380" MappingRef="OMIM">
        <MedGen CUI="C1848578" Name="Methylmalonic aciduria and homocystinuria type cblF" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="499714" TraitType="Disease" MappingType="Name" MappingValue="Inborn genetic diseases" MappingRef="Preferred">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6043649" TraitType="Disease" MappingType="XRef" MappingValue="CN043592" MappingRef="MedGen">
        <MedGen CUI="CN043592" Name="Disorders of Intracellular Cobalamin Metabolism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3001966" TraitType="Disease" MappingType="XRef" MappingValue="277380" MappingRef="OMIM">
        <MedGen CUI="C1848578" Name="Methylmalonic aciduria and homocystinuria type cblF" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464018" TraitType="Disease" MappingType="XRef" MappingValue="277380" MappingRef="OMIM">
        <MedGen CUI="C1848578" Name="Methylmalonic aciduria and homocystinuria type cblF" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790250" TraitType="Disease" MappingType="XRef" MappingValue="277380" MappingRef="OMIM">
        <MedGen CUI="C1848578" Name="Methylmalonic aciduria and homocystinuria type cblF" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

